Not Signed In -
Ranitidine |
Zantac; Zantac 75 |
Ranitidine Systematic (IUPAC) name (E)-N-(2-((5-((dimethylaminomethyl) furan-2-yl)methylthio)ethyl)- N'-methyl-2-nitroethene-1,1-diamine Identifiers CAS number 66357-35-5 ATC code A02BA02 PubChem 3001055 DrugBank APRD00254 Chemical data Formula C13H22N4O3S Mol. weight 314.4 Pharmacokinetic data Bioavailability 39–88% Metabolism hepatic Half life 2–3 hours Excretion 30–70% renal Therapeutic considerations Pregnancy cat. B1 (Aust) Legal status ...
Wikipedia - [full article]
Ranitidine Clinical Trials
- A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3
ClinicalTrials.gov Identifier: NCT00002106 - Completed
HIV Infections
- Medical Treatment for GERD in Preterm Infants
ClinicalTrials.gov Identifier: NCT00131248 - Recruiting
Gastroesophageal Reflux
- Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-Induced Gastric Ulcer
ClinicalTrials.gov Identifier: NCT00401752 - Recruiting
Gastric Ulcer
- Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
ClinicalTrials.gov Identifier: NCT00527878 - Recruiting
Job's Syndrome; Hyper-IgE Recurrent Infection Syndrome; Immune Deficiency
- A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.
ClinicalTrials.gov Identifier: NCT00405119 - Completed
Gastroesophageal Reflux Disease
- The Effect of Stomach Acid on Foscarnet
ClinicalTrials.gov Identifier: NCT00000964 - Completed
HIV Infections
- Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
ClinicalTrials.gov Identifier: NCT00161200 - Terminated
Esophageal Metaplasia
email this page
print this page
bookmark this page
feedback on this page
